Last reviewed · How we verify
NCT06751550: Asthma FeNO
Changes in FeNO Value During Pulmonary Rehabilitation in Patients with Asthma
trial in Asthma Bronchiale in 62 participants. Completed in 20 December 2024.
20 December 2024
Quick facts
| Lead sponsor | Schön Klinik Berchtesgadener Land |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 62 |
| Start date | 17 May 2021 |
| Primary completion | 20 December 2024 |
| Estimated completion | 20 December 2024 |
| Sites | 1 location across Germany |
Conditions studied
- Asthma Bronchiale — all drugs for Asthma Bronchiale →
- Asthmatic Patients — all drugs for Asthmatic Patients →
- Asthmatics — all drugs for Asthmatics →
Sponsor
Schön Klinik Berchtesgadener Land
Who can join
18 and older, any sex, with Asthma Bronchiale or Asthmatic Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the use of fractional exhaled nitric oxide (FeNO) measurement to monitor non-pharmacological therapy during a three-week inpatient rehabilitation programme for asthma patients. It compares FeNO levels (measured three times a day) with clinical parameters and quality of life to analyse daily fluctuations and the acute effect of exercise training on FeNO levels. As FeNO is a non-invasive biomarker of airway inflammation, this study aims to expand its role in therapy monitoring and explore its application in a rehabilitation setting.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pulmonary Rehabilitation Reduces Airway Inflammation in Asthma Patients with High Fe<sub>NO</sub> Levels.
Gloeckl R, Kroll D, Abdulleyev G, Schneeberger T, et al · · 2025 · PMID 41311909 · DOI 10.2147/jaa.s555317
Verify or expand the search:
- PubMed search for NCT06751550
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asthma Bronchiale
Currently open trials in the same condition.
- NCT06831994 — Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity · NA · recruiting
- NCT06966271 — Investigation of the Respiratory Profile of Patients With Obstructive Pulmonary Disease (ASTHMA, COPD) · recruiting
- NCT06636487 — Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD · NA · active not recruiting
- NCT06678191 — Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting · recruiting
- NCT06842836 — Evaluation of Alterations in the Gut Microbiota in Pediatric Bronchial Asthma · active not recruiting
Other Schön Klinik Berchtesgadener Land trials
Trials by the same sponsor.
- NCT07013903 — Effects of Hydrotherapy During Post-COVID-19 Rehabilitation · NA · recruiting
- NCT06545851 — Effects of an Automatic Oxygen Titration System in People With Hypoxemia During Exercise Training · NA · recruiting
- NCT05172206 — Symptom-based Rehabilitation Compared to Usual Care in Post-COVID - a Randomized Controlled Trial · NA · completed
- NCT05124548 — Sleep Characteristics in Post-COVID-19 Patients · completed
- NCT05126511 — Effects of Cranial Electrotherapy Stimulation on Anxiety of Patients After COVID-19 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06751550 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Schön Klinik Berchtesgadener Land
- Last refreshed: 8 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06751550.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing